Perimenopause and Mental Health: Depression, Anxiety, ADHD, and Brain Fog

Perimenopause is the transition leading up to menopause, when the ovaries gradually wind down, and estrogen and progesterone levels swing unpredictably before declining. It usually begins in a woman’s 40s – sometimes earlier – and can last anywhere from a few years to a decade. Estrogen does far more than regulate the menstrual cycle: it helps modulate serotonin, dopamine, and norepinephrine, the same brain chemicals targeted by many mental health treatments. When estrogen becomes erratic, so can mood, sleep, attention, and stress tolerance.

That is why the menopause transition is often described as a window of vulnerability for mental health. In the same LifeStance survey, 36% of women were surprised these symptoms could mask as standalone mental health conditions, and 49% were surprised they could last for years, which is part of why they so often go unrecognized.

Depression is one of the clearest examples. A 2024 meta-analysis found perimenopausal women had a 40% higher risk of depression than premenopausal women, and the odds are higher still for women who have lived with depression before. However, even women with no prior history of depression face elevated risk during perimenopause – a sign that biology, not just circumstance, is a driving force.

The depression that shows up in perimenopause can look very different from typical symptoms of major depressive disorder. Alongside low mood, women often describe irritability, tearfulness, loss of motivation, and a flatness that seems disconnected from life circumstances. According to the LifeStance survey, 54% rated their depression as somewhat or extremely severe, yet 39% initially assumed their symptoms were depression as a standalone condition rather than part of a hormonal shift.

That distinction shapes care, and for a woman whose depression appears for the first time in her 40s or 50s, the hormonal shift can move to front and center rather than being incidental. Addressing it directly can be an important part of feeling better. In these cases, a psychiatrist will often work closely with a woman’s primary care provider or gynecologist to weigh hormonal options. A randomized trial in Archives of General Psychiatry found that estrogen therapy relieved depressive symptoms more effectively than a placebo in perimenopausal women. Hormone therapy (often called HRT) is now considered a reasonable option for some women when the timing and their medical history make it appropriate. Because hormones, sleep, and life stress can all contribute, care during this stage often combines therapy, lifestyle support, and, when appropriate, medication or hormonal treatment coordinated across a woman’s care team.

Anxiety is one of the most common but under-recognized mental health symptoms of perimenopause. A 2024 study in Frontiers in Psychiatry found that women in early perimenopause were more bothered by feelings of depression and anxiety than postmenopausal women, with distress peaking in that early transitional window. Fluctuating estrogen appears to heighten the body’s stress response, which can translate into racing thoughts, a pounding heart, and a constant sense of unease.

For women who have never dealt with it before, anxiety in midlife can be disorienting. The LifeStance survey found that 66% described their anxiety as somewhat or extremely severe, and 49% first assumed the feeling was anxiety on its own. Physical symptoms such as heart palpitations, dizziness, and broken sleep can amplify the fear, sometimes tipping into panic. Learning that these sensations have a hormonal driver can be reassuring in itself, and evidence-based treatment can help calm both the mind and the nervous system.

One of the most overlooked connections is between perimenopause and attention. Estrogen supports dopamine – the neurotransmitter central to focus, motivation, and working memory – so as estrogen falls, attention problems can surface or intensify. A 2025 population-based cohort study in European Psychiatry found that women with ADHD were nearly 1.8 times more likely to report severe perimenopausal symptoms than women without ADHD, and that symptoms tended to appear at an earlier age.

Just as important, some women reach midlife and discover ADHD for the first time, because the coping strategies that once masked it stop working when estrogen drops. New forgetfulness, disorganization, and trouble following through can be dismissed as stress or early cognitive decline. A thorough ADHD evaluation can clarify whether attention symptoms reflect ADHD, hormonal change, or both, and it helps to know that ADHD often shows up differently in women than the familiar stereotype suggests. When ADHD is present, ADHD treatment can be tailored to a woman’s changing needs across the transition.

Brain fog is the symptom women describe most vividly: walking into a room and forgetting why, losing words mid-sentence, or struggling to concentrate on tasks that used to feel automatic. It’s common enough that researchers have studied it directly. The Study of Women’s Health Across the Nation documented measurable dips in processing speed and verbal learning during perimenopause, with cognition largely rebounding after the transition. In other words, perimenopausal brain fog is usually hormonal and usually temporary, not an early sign of dementia as many women often fear.

Poor sleep, anxiety, and low mood all degrade concentration, so the cognitive symptoms and the emotional ones tend to feed one another. Addressing sleep and stress often sharpens focus as a side effect, which is one reason a whole-picture approach tends to work better than treating each symptom in isolation.

So many women experience it that it has earned a name of its own: perimenopausal rage. The term describes the sudden, outsized flashes of anger that can erupt over something small – a partner who left dishes in the sink, a slow driver, a question asked one too many times – and then fade just as fast, often leaving guilt and confusion behind. Much of it plays out at home. Scroll through social media and the term trends under its own hashtags, with countless women describing anger that surfaces most often toward the people closest to them, partners especially. It’s one of the most relatable, and least talked-about, symptoms of the transition.

In the LifeStance survey, 66% rated irritability and 62% rated mood swings as somewhat or extremely severe. These shifts are tied to the same hormonal volatility behind anxiety and depression – they are not a character flaw or a failure of willpower.

For some women, the premenstrual mood symptoms they had earlier in life intensify during perimenopause, overlapping with conditions such as PMDD. Tracking symptoms across the month can help a provider distinguish hormone-driven mood changes from a mood disorder that needs its own treatment plan, and often the two are managed together.

Sleep is often the first thing to unravel in perimenopause, and one of the most consequential. A 2025 review in the Journal of Clinical Medicine reports that sleep problems affect 16% to 47% of women during perimenopause and climb to as much as 60% after menopause. The causes are largely hormonal: estrogen helps quiet the brain chemicals that trigger waking, and progesterone has a natural calming, sedative effect through the same GABA pathway involved in relaxation. As both hormones fluctuate and decline, sleep grows lighter and more broken, while night sweats and hot flashes fragment it further.

Sleep and mood are also associated. Too little sleep can deepen anxiety, irritability, and low mood, which can make sleep harder to come by, creating a self-reinforcing cycle. Because poor sleep affects mental health, sleep loss is often the hidden driver behind daytime symptoms that get mistaken for a standalone mood disorder. Protecting sleep – through steadier sleep habits, using strategies from Cognitive Behavioral Therapy for Insomnia (CBT-I), easing night sweats, or addressing the hormonal shift itself – can be a meaningful way to steady mood during the transition.

The symptoms of perimenopause can look identical to standalone depression, anxiety, or ADHD, which makes them easy to mistake for those conditions, both by women themselves and sometimes by their providers. In the LifeStance survey, 74% of women had symptoms for six months or longer before suspecting perimenopause, and nearly half assumed the problem was anxiety alone. Several factors may feed that gap:

• Overlapping screening tools. Standard depression questionnaires ask about fatigue, sleep, appetite, and concentration – the very symptoms fluctuating estrogen produces – so a hormonal shift can register as clinical depression on paper.
• Diagnostic overshadowing. In women in their 40s and 50s, mood and anxiety symptoms are often treated as isolated psychiatric conditions rather than signs of a hormonal transition.
• Symptoms that come and go. Perimenopausal mood changes tend to be episodic and tied to the menstrual cycle, unlike the steady, persistent low mood of classic depression.
• Sleep at the root. Insomnia and night sweats often precede and fuel emotional distress, yet the underlying sleep loss is rarely treated as the trigger.
• Dismissed symptoms. Midlife complaints are too often chalked up to stress, aging, or lifestyle rather than explored as perimenopause.

Naming perimenopause as a possible driver doesn’t rule out depression, anxiety, or ADHD, but it keeps hormones in the conversation so the whole picture can be treated.

Perimenopausal mental health symptoms are often very treatable. In the LifeStance survey, 83% of women who tried therapy found it helpful, and 82% found prescribed medication helpful. Care works best when it is individualized and addresses several layers at once:

• Therapy. Talk therapy, and cognitive behavioral therapy (CBT) in particular, can help women manage anxious and depressive thinking, develop insight into the role of perimenopause on symptoms, adjust to a changing body, and rebuild healthy routines. CBT for Insomnia can help with sleep issues, as well. Nearly half of survey respondents (47%) felt therapy should be a standard part of perimenopause care.
• Medication, when appropriate. Antidepressants can help with mood and anxiety symptoms through ongoing medication management. Medication is only prescribed when a clinician determines it is appropriate and should be taken only as prescribed.
• Hormonal care. Because these symptoms are often driven by shifting estrogen and progesterone, a gynecologist or primary care provider can assess whether menopause hormone therapy (HRT) is appropriate, typically estrogen, as a patch, gel, or pill, often paired with progesterone and matched to a woman’s symptoms and health history. Coordinating it with a psychiatrist lets hormonal and mental health care work together.
• Lifestyle foundations. Regular movement, protected sleep, stress reduction, and practices such as mindfulness support both hormonal balance and mental health, and can help other treatments work better.

There is no need to white-knuckle through perimenopause. It may be time to reach out if low mood, anxiety, irritability, or brain fog last more than two weeks, interfere with work or relationships, or feel unmanageable. A good starting point is a conversation with a therapist or a psychiatrist, often working with a gynecologist or primary care provider who can address the hormonal side and help make sense of the full picture.

Support can make a real difference. According to a 2026 outcomes data report, 79% of LifeStance individuals experienced clinically significant improvement in anxiety symptoms and 73% in depression symptoms* with evidence-based care. Perimenopause is a transition, not a permanent state, and with the right support, the mental health symptoms that come with it can improve too.

*amongst 140,000 LifeStance patients with at least moderate anxiety and 150,000 with at least moderate depression